학술논문

MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation
Document Type
Article
Source
In: Cancer Research. (Cancer Research, 1 January 2014, 74(1):253-262)
Subject
Language
English
ISSN
00085472
15387445